CMPF (CAS 86879-39-2)
See product citations (1)
QUICK LINKS
CMPF is an endogenous metabolite of furan fatty acids, naturally found in phospholipids, that is highly albumin-bound. CMPF functions to inhibit cellular transport and subsequent deiodination of thyroxine (T4). In addition, CMPF functions by displacing competitive T4 molecules from indirectly binding to albumin. It is believed that CMPF inhibits this binding by increasing the serum concentration of competitive binding molecules such as free fatty acids. Furthermore, CMPF is an organophosphate BChE (cholinesterase) inhibitor. CMPF is a naturally occurring carboxylic acid present in the human body, playing a role in diverse biochemical and physiological processes. It is primarily found in the liver, heart, and brain, participating in metabolic pathways associated with cholesterol, fatty acid, and lipid synthesis.
CMPF (CAS 86879-39-2) References
- Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys. | Koplovitz, I., et al. 1992. Arch Toxicol. 66: 622-8. PMID: 1482284
- Protein-bound toxins--update 2009. | Jourde-Chiche, N., et al. 2009. Semin Dial. 22: 334-9. PMID: 19708977
- A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate. | Miyamoto, Y., et al. 2012. Biochem Pharmacol. 84: 1207-14. PMID: 22898098
- Removal of protein-bound uraemic toxins by haemodialysis. | Niwa, T. 2013. Blood Purif. 35 Suppl 2: 20-5. PMID: 23676831
- Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development. | Liu, Y., et al. 2016. Cell Rep. 14: 2889-900. PMID: 26997281
- Synthesis and Characterization of Urofuranoic Acids: In Vivo Metabolism of 2-(2-Carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic Acid (CMPF) and Effects on in Vitro Insulin Secretion. | Nagy, E., et al. 2017. J Med Chem. 60: 1860-1875. PMID: 28171722
- CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis. | Prentice, KJ., et al. 2018. EBioMedicine. 27: 200-213. PMID: 29290411
- Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients? | Luce, M., et al. 2018. Toxins (Basel). 10: PMID: 29783628
- Evaluation of MASP1, CMPF and U.A serum levels in pre-diabetic subjects in comparison to Normal individuals for early diagnosis of subjects with pre-diabetes, a case-control study. | Fardipour, S., et al. 2020. J Diabetes Metab Disord. 19: 1593-1598. PMID: 33520855
- Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0. | Ruszała, M., et al. 2022. Int J Mol Sci. 23: PMID: 35457182
- The Piezo1 hypothesis of renal anemia. | Kotanko, P., et al. 2022. FASEB Bioadv. 4: 436-440. PMID: 35812074
- The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study. | Dai, L., et al. 2022. Am J Clin Nutr. 116: 1842-1851. PMID: 36166845
- A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum. | Lim, CF., et al. 1993. Metabolism. 42: 1468-74. PMID: 8231843
- A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. | Lim, CF., et al. 1993. J Clin Endocrinol Metab. 76: 318-24. PMID: 8432774
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CMPF, 500 µg | sc-204695 | 500 µg | $39.00 | |||
CMPF, 1 mg | sc-204695A | 1 mg | $133.00 |